Astera Labs (NASDAQ:ALAB) General Counsel Philip Mazzara Sells 10,000 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.77, for a total value of $1,077,700.00. Following the completion of the transaction, the general counsel directly owned 118,084 shares in the company, valued at approximately $12,725,912.68. This trade represents a 7.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Philip Mazzara also recently made the following trade(s):

  • On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $117.47, for a total value of $1,174,700.00.
  • On Tuesday, February 17th, Philip Mazzara sold 4,849 shares of Astera Labs stock. The stock was sold at an average price of $123.80, for a total value of $600,306.20.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $117.14 on Friday. The firm has a market cap of $20.06 billion, a P/E ratio of 96.02, a P/E/G ratio of 2.31 and a beta of 1.78. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The stock’s fifty day moving average price is $131.56 and its 200-day moving average price is $159.64.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. During the same period in the prior year, the firm earned $0.37 earnings per share. The firm’s revenue for the quarter was up 91.8% compared to the same quarter last year. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Key Headlines Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Citi initiated/maintained a Buy and set a $200 price target on ALAB, highlighting PCIe and AI-infrastructure opportunity — a sizable analyst endorsement that can lift sentiment and buying interest. Benzinga Coverage
  • Positive Sentiment: Research notes (TipRanks summary) underscore Astera Labs’ PCIe switch leadership and positioning in rack-scale AI connectivity, framing multiyear revenue upside tied to data-center AI buildouts. Astera Labs: Leveraging PCIe Switch Leadership…
  • Positive Sentiment: Astera appears on roundups of leading growth stocks with notable insider ownership — a signal some investors use to judge management alignment and conviction, which can support valuation multiple expansion if execution continues. April 2026’s Leading Growth Stocks With Insider Ownership
  • Neutral Sentiment: Company announced it will report Q1 2026 results after market close on May 5 and hold a conference call — an imminent catalyst that could swing the stock depending on revenue, margins and guidance. Astera Labs Announces Conference Call…
  • Negative Sentiment: Recent articles flag a ~36% YTD decline and call out margin pressure and intensifying competition as key near-term risks; these concerns help explain the share-price pullback despite top-line AI/PCIe tailwinds. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD?
  • Negative Sentiment: Analyst commentary and newsletter pieces emphasize margin compression risks even as demand grows — if margins miss or competition accelerates, upside expectations tied to AI/PCIe could be delayed. Should You Hold on to Astera Labs Stock Despite Its 36% Dip in YTD? (Zacks)

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on ALAB shares. Northland Securities lifted their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Royal Bank Of Canada began coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 target price on the stock. Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, February 23rd. Citigroup started coverage on Astera Labs in a research note on Thursday. They set a “buy” rating and a $200.00 price objective for the company. Finally, Loop Capital assumed coverage on Astera Labs in a research report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective on the stock. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $199.44.

View Our Latest Stock Report on Astera Labs

Hedge Funds Weigh In On Astera Labs

Several institutional investors and hedge funds have recently bought and sold shares of ALAB. Assetmark Inc. increased its position in shares of Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Reflection Asset Management acquired a new stake in shares of Astera Labs in the 4th quarter worth $25,000. Smartleaf Asset Management LLC grew its stake in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Hilltop National Bank increased its position in Astera Labs by 100.0% during the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares in the last quarter. Finally, Aventura Private Wealth LLC purchased a new stake in Astera Labs in the fourth quarter valued at about $33,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Read More

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.